Xeris Appoints John Shannon as New Board Chair and Adds Dr. Nerissa Kreher
Xeris Biopharma announced CEO John Shannon will assume the role of Chair of the Board following a transition by Marla Persky. The company also appointed Dr. Nerissa Kreher, adding a new executive with rare disease expertise to strengthen its biopharmaceutical leadership.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day